Bellecapital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,739
| Closed | -$1.6M | – | 141 |
|
|
2026
Q1 | $1.6M | Buy |
1,739
+13
| +0.8% | +$13.2K | 0.29% | 48 |
|
|
2025
Q4 | $1.85M | Sell |
1,726
-9
| -0.5% | -$8.61K | 0.33% | 42 |
|
|
2025
Q3 | $1.32M | Sell |
1,735
-166
| -9% | -$124K | 0.21% | 53 |
|
|
2025
Q2 | $1.48M | Sell |
1,901
-100
| -5% | -$77.7K | 0.26% | 50 |
|
|
2025
Q1 | $1.65M | Sell |
2,001
-218
| -10% | -$181K | 0.33% | 47 |
|
|
2024
Q4 | $1.71M | Buy |
2,219
+150
| +7% | +$124K | 0.3% | 49 |
|
|
2024
Q3 | $1.83M | Sell |
2,069
-1,019
| -33% | -$916K | 0.36% | 49 |
|
|
2024
Q2 | $2.8M | Sell |
3,088
-728
| -19% | -$582K | 0.59% | 41 |
|
|
2024
Q1 | $2.97M | Hold |
3,816
| – | – | 0.65% | 40 |
|
|
2023
Q4 | $2.22M | Buy |
3,816
+68
| +2% | +$39.7K | 0.5% | 46 |
|
|
2023
Q3 | $2.01M | Sell |
3,748
-906
| -19% | -$467K | 0.5% | 48 |
|
|
2023
Q2 | $2.18M | Sell |
4,654
-305
| -6% | -$128K | 0.53% | 48 |
|
|
2023
Q1 | $1.7M | Hold |
4,959
| – | – | 0.42% | 53 |
|
|
2022
Q4 | $1.81M | Sell |
4,959
-241
| -5% | -$85.4K | 0.51% | 45 |
|
|
2022
Q3 | $1.68M | Sell |
5,200
-87
| -2% | -$27.6K | 0.51% | 45 |
|
|
2022
Q2 | $1.71M | Sell |
5,287
-43
| -0.8% | -$12.9K | 0.48% | 48 |
|
|
2022
Q1 | $1.53M | Hold |
5,330
| – | – | 0.48% | 43 |
|
|
2021
Q4 | $1.47M | Sell |
5,330
-22
| -0.4% | -$5.58K | 0.42% | 52 |
|
|
2021
Q3 | $1.24M | Hold |
5,352
| – | – | 0.38% | 56 |
|
|
2021
Q2 | $1.23M | Hold |
5,352
| – | – | 0.37% | 57 |
|
|
2021
Q1 | $1M | Sell |
5,352
-107
| -2% | -$20.9K | 0.31% | 61 |
|
|
2020
Q4 | $922K | Sell |
5,459
-75
| -1% | -$11.2K | 0.31% | 61 |
|
|
2020
Q3 | $819K | Buy |
5,534
+430
| +8% | +$66.5K | 0.37% | 53 |
|
|
2020
Q2 | $838K | Hold |
5,104
| – | – | 0.39% | 55 |
|
|
2020
Q1 | $708K | Buy |
5,104
+236
| +5% | +$32.4K | 0.45% | 51 |
|
|
2019
Q4 | $640K | Sell |
4,868
-431
| -8% | -$50K | 0.33% | 68 |
|
|
2019
Q3 | $593K | Sell |
5,299
-70
| -1% | -$7.79K | 0.36% | 63 |
|
|
2019
Q2 | $595K | Buy |
5,369
+250
| +5% | +$29.4K | 0.37% | 59 |
|
|
2019
Q1 | $664K | Buy |
5,119
+1,202
| +31% | +$146K | 0.42% | 54 |
|
|
2018
Q4 | $453K | Buy |
3,917
+1,315
| +51% | +$147K | 0.32% | 60 |
|
|
2018
Q3 | $279K | Hold |
2,602
| – | – | 0.18% | 70 |
|
|
2018
Q2 | $222K | Hold |
2,602
| – | – | 0.16% | 81 |
|
|
2018
Q1 | $201K | Hold |
2,602
| – | – | 0.19% | 80 |
|
|
2017
Q4 | $220K | Buy |
+2,602
| New | +$221K | 0.18% | 72 |
|
|
2017
Q1 | – | Sell |
-2,800
| Closed | -$206K | – | 83 |
|
|
2016
Q4 | $206K | Hold |
2,800
| – | – | 0.18% | 75 |
|
|
2016
Q3 | $219K | Hold |
2,800
| – | – | 0.24% | 61 |
|
|
2016
Q2 | $213K | Buy |
+2,800
| New | +$211K | 0.23% | 58 |
|
Other funds holding LLY
Bellecapital's LLY Position: Q2 2026 in Review
Bellecapital sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,739 shares — an estimated $1.6M sold.
Bellecapital first reported a position in LLY in Q2 2016 and held it in 37 quarters. The position peaked at $2.97M in Q1 2024. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bellecapital reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- Bellecapital sold 1,739 Eli Lilly shares in Q2 2026, an estimated $1.6M.
- Bellecapital first reported a position in Eli Lilly in Q2 2016 and held it in 37 quarters.
- Bellecapital's Eli Lilly position peaked at $2.97M in Q1 2024.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bellecapital's 13F filing for Q2 2026, filed 22 Jul 2026.